SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Biotech / MedicalCutera


Previous 10 
From: Harshu Vyas3/5/2024 12:58:14 PM
   of 21
 
Before and After Acne Laser Results You Have to See to Believe (newbeauty.com)

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/6/2024 12:24:06 PM
   of 21
 
Based on the Company's current plans, the Company believes that its current cash and cash equivalents and anticipated cash flow from operations will be sufficient to meet its anticipated cash requirements for at least the next twelve months. If the Company's available cash resources and cash flow from operations are insufficient to satisfy its liquidity requirements including because of lower demand for its products or the realization of other risks described in its Annual Report, the Company may be required to raise additional capital through the issuances of additional equity or convertible debt securities, enter into a credit facility or another form of third-party funding or seek other debt financing.The various ways the Company could raise additional capital carry potential risks. If the Company raises funds by issuing equity securities, dilution to its stockholders would result. If the Company raises funds by issuing debt securities, those debt securities would have rights, preferences and privileges senior to those of holders of the Company's common stock. The terms of debt securities issued or borrowings pursuant to a credit agreement could impose significant restrictions on the Company's operations and present the risk of default. If the Company raises funds through collaborations or licensing arrangements, the Company may be required to relinquish significant rights to its technologies or products or grant licenses on terms that are not favorable to the Company.If the Company is unable to obtain adequate financing or financing on terms satisfactory to the Company, if the Company requires it, the Company's ability to continue to pursue its business objectives and to respond to business opportunities, challenges, or unforeseen circumstances could be significantly limited, and could have a material adverse effect on the Company's business, financial condition, results of operations and prospects.


This additional risk factor is what worries me. The idea that they know they need additional financing. At current levels, convertible notes would kill the stock, but may be the best choice as it buys them time. I'd say management need to get the stock higher, though, before they refi their convertibles.

Vanilla equity would crash the stock, debt is impossible and licensing arrangements for such a small company gets rid of its chance of being more valuable.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/12/2024 6:36:46 AM
   of 21
 
AviClear now available in the Middle East! I noticed the Cutera sales force + Taylor Harris were positioned in Abu Dhabi so it's not all too surprising.

Either way, my conclusion is that AviClear is going global!

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/13/2024 1:02:17 PM
   of 21
 
When this is all over, I swear to never buy another company like Cutera again. It's a nightmare stock and not an enjoyable ride at all.

To think I've been involved with this company for more than five months is a crime in itself.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/18/2024 3:32:00 PM
   of 21
 
Volume has dried up - imagine it will pick up on the 20th and the days following the conference call on the 21st (as it has in the past).

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/19/2024 7:37:02 AM
   of 21
 
Couple things -

  1. Cutera Introduces Cutera Academy and New Business Model for AviClear Customers - The Dermatology Digest (thedermdigest.com)
  2. The 10K has been delayed and that was the reason for the plummet yesterday. The reasoning - they spent so long checking the last few quarterlies, they haven't had enough time to prepare their 10K. Hopefully, this won't happen every time they need to file a 1OQ/10K.


In real-time, I'm getting the impression that we've past the worst of the turn-around in the last couple of weeks. I think we'll begin to see AviClear's real potential from 2Q onwards. 1Q may be better than expected, too.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/21/2024 3:43:44 PM
   of 21
 
My understanding of convertible notes is slightly off.

Cutera need to get their share price UP for more shares to be issued. Otherwise, noteholders will demand cash. Given where the share price is currently, noteholders will demand $70m cash in 2026. Possible to achieve, but I think I'd prefer dilution as an owner!

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas3/22/2024 8:05:00 AM
   of 21
 
I was wrong about Cutera. I've dropped my PT from $10 to $5 and am looking to get out quickly and cheaply. Any spike from here and I'll sell. This will clearly take much longer than I thought. Not only that, but it seems the only way out for shareholders is a buyout. Insolvency is on the cards.

It's likely with Harris as CEO that a buyout does occur, but the pure turnaround is unlikely, breaking my initial thesis. Lessons have been learned and ultimately this comes down to the excessive cash burn. A $90m cash burn forecasted for this year is just too much for me to get my head around.

Am going to research JD, IRBT, VFC and a few other stocks so I have an idea of what I'm going to put the leftovers into.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: Harshu Vyas who wrote (19)3/22/2024 9:53:26 AM
From: Harshu Vyas
   of 21
 
I sold at the open.

Share RecommendKeepReplyMark as Last Read


From: Harshu Vyas5/3/2024 10:59:32 AM
   of 21
 
CUTR - up over 75% in the last month. I sold on their last earnings and am waiting for their cash flows to stabilise. Q1 and Q2 will be rough, though it may already be priced in - management have to fulfil massive inventory obligations that will soak up precious cash. What I'm really looking for is an insider buy in the next two qtrs.

I think refinancing the convertibles is actually more easy than it may seem - especially if they can make a profit. I think they should be able to settle the $70m in cash in 2026. It's still a long way away and my understanding is the core business will stabilise this year.

Share RecommendKeepReplyMark as Last Read
Previous 10